Published in Antimicrob Agents Chemother on July 01, 1984
Molecular basis of bacterial outer membrane permeability revisited. Microbiol Mol Biol Rev (2003) 13.49
Agents that increase the permeability of the outer membrane. Microbiol Rev (1992) 7.52
Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob Agents Chemother (2001) 5.23
Photodynamic therapy: a new antimicrobial approach to infectious disease? Photochem Photobiol Sci (2004) 4.60
Interaction of polycationic antibiotics with Pseudomonas aeruginosa lipopolysaccharide and lipid A studied by using dansyl-polymyxin. Antimicrob Agents Chemother (1986) 2.74
Extracellular DNA chelates cations and induces antibiotic resistance in Pseudomonas aeruginosa biofilms. PLoS Pathog (2008) 2.71
Killing of gram-negative bacteria by lactoferrin and lysozyme. J Clin Invest (1991) 2.54
Antibiotic combinations: should they be tested? Clin Microbiol Rev (1988) 2.34
Interaction of macrophage cationic proteins with the outer membrane of Pseudomonas aeruginosa. Infect Immun (1988) 1.92
Binding of polycationic antibiotics and polyamines to lipopolysaccharides of Pseudomonas aeruginosa. J Bacteriol (1985) 1.90
Involvement of outer membrane of Pseudomonas cepacia in aminoglycoside and polymyxin resistance. Antimicrob Agents Chemother (1986) 1.87
Synthesis, processing, and transport of Pseudomonas aeruginosa elastase. J Bacteriol (1988) 1.67
Binding of polymyxin B nonapeptide to gram-negative bacteria. Antimicrob Agents Chemother (1985) 1.67
Improvement of outer membrane-permeabilizing and lipopolysaccharide-binding activities of an antimicrobial cationic peptide by C-terminal modification. Antimicrob Agents Chemother (1994) 1.51
Salicylate-inducible antibiotic resistance in Pseudomonas cepacia associated with absence of a pore-forming outer membrane protein. Antimicrob Agents Chemother (1992) 1.50
Rhamnolipid stimulates uptake of hydrophobic compounds by Pseudomonas aeruginosa. Appl Environ Microbiol (2002) 1.41
Multidrug resistance of a porin deletion mutant of Mycobacterium smegmatis. Antimicrob Agents Chemother (2004) 1.34
Cationic fullerenes are effective and selective antimicrobial photosensitizers. Chem Biol (2005) 1.28
Effect of small cationic leukocyte peptides (defensins) on the permeability barrier of the outer membrane. Infect Immun (1988) 1.27
Pseudomonas aeruginosa reveals high intrinsic resistance to penem antibiotics: penem resistance mechanisms and their interplay. Antimicrob Agents Chemother (2001) 1.26
Interaction of aminoglycosides with the outer membranes and purified lipopolysaccharide and OmpF porin of Escherichia coli. Antimicrob Agents Chemother (1991) 1.22
MexCD-OprJ multidrug efflux system of Pseudomonas aeruginosa: involvement in chlorhexidine resistance and induction by membrane-damaging agents dependent upon the AlgU stress response sigma factor. Antimicrob Agents Chemother (2008) 1.17
Enhanced binding of polycationic antibiotics to lipopolysaccharide from an aminoglycoside-supersusceptible, tolA mutant strain of Pseudomonas aeruginosa. Antimicrob Agents Chemother (1988) 1.17
Beta-lactam antibiotics potentiate magainin 2 antimicrobial activity in vitro and in vivo. Antimicrob Agents Chemother (1991) 1.15
Azithromycin exhibits bactericidal effects on Pseudomonas aeruginosa through interaction with the outer membrane. Antimicrob Agents Chemother (2005) 1.12
Antibiotic adjuvants: diverse strategies for controlling drug-resistant pathogens. Chem Biol Drug Des (2015) 1.08
Evaluation of multidrug efflux pump inhibitors by a new method using microfluidic channels. PLoS One (2011) 1.07
Surface-localized spermidine protects the Pseudomonas aeruginosa outer membrane from antibiotic treatment and oxidative stress. J Bacteriol (2011) 1.07
Resistance to pefloxacin in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1991) 1.06
Multifunctional role of human SPLUNC1 in Pseudomonas aeruginosa infection. Infect Immun (2012) 1.06
Use of steroids to monitor alterations in the outer membrane of Pseudomonas aeruginosa. J Bacteriol (1997) 1.04
Effects of single D-amino acid substitutions on disruption of beta-sheet structure and hydrophobicity in cyclic 14-residue antimicrobial peptide analogs related to gramicidin S. J Pept Res (2004) 1.03
Sodium hexametaphosphate sensitizes Pseudomonas aeruginosa, several other species of Pseudomonas, and Escherichia coli to hydrophobic drugs. Antimicrob Agents Chemother (1989) 1.02
Antimicrobial susceptibility of Salmonella typhimurium carrying the outer membrane permeability mutation SS-B. Antimicrob Agents Chemother (1990) 1.01
Structural correlates of antibacterial and membrane-permeabilizing activities in acylpolyamines. Antimicrob Agents Chemother (2006) 1.00
Selective inhibition of the accumulation of extracellular proteases of Pseudomonas aeruginosa by gentamicin and tobramycin. Antimicrob Agents Chemother (1985) 0.99
Extreme antimicrobial Peptide and polymyxin B resistance in the genus burkholderia. Front Microbiol (2011) 0.98
Role of beta-lactamase in in vivo development of ceftazidime resistance in experimental Pseudomonas aeruginosa endocarditis. Antimicrob Agents Chemother (1987) 0.96
Initial characterization of two extracellular autolysins from Pseudomonas aeruginosa PAO1. J Bacteriol (1994) 0.95
Potentiation of antibacterial activity of azithromycin and other macrolides by normal human serum. Antimicrob Agents Chemother (1992) 0.94
Mechanism of action and initial evaluation of a membrane active all-D-enantiomer antimicrobial peptidomimetic. Proc Natl Acad Sci U S A (2013) 0.93
Comparative analysis of selected methods for the assessment of antimicrobial and membrane-permeabilizing activity: a case study for lactoferricin derived peptides. BMC Microbiol (2008) 0.92
The biofilm matrix destabilizers, EDTA and DNaseI, enhance the susceptibility of nontypeable Hemophilus influenzae biofilms to treatment with ampicillin and ciprofloxacin. Microbiologyopen (2014) 0.92
Poly(ethylene imine)s as antimicrobial agents with selective activity. Macromol Biosci (2012) 0.91
Extreme antimicrobial peptide and polymyxin B resistance in the genus Burkholderia. Front Cell Infect Microbiol (2011) 0.90
The time course of hydrolysis of a beta-lactam antibiotic by intact gram-negative bacteria possessing a periplasmic beta-lactamase. Biochem J (1987) 0.89
The oligo-acyl lysyl antimicrobial peptide C₁₂K-2β₁₂ exhibits a dual mechanism of action and demonstrates strong in vivo efficacy against Helicobacter pylori. Antimicrob Agents Chemother (2011) 0.87
In vitro characterization of the anti-bacterial activity of SQ109 against Helicobacter pylori. PLoS One (2013) 0.87
Mutant Alleles of lptD Increase the Permeability of Pseudomonas aeruginosa and Define Determinants of Intrinsic Resistance to Antibiotics. Antimicrob Agents Chemother (2015) 0.82
Selection of an antibiotic-hypersusceptible mutant of Pseudomonas aeruginosa: identification of the GlmR transcriptional regulator. Antimicrob Agents Chemother (2004) 0.82
Design of catalytically amplified sensors for small molecules. Biomolecules (2014) 0.79
Rapid assessment of the physiological status of the polychlorinated biphenyl degrader Comamonas testosteroni TK102 by flow cytometry. Appl Environ Microbiol (2002) 0.79
Synergistic anti-Campylobacter jejuni activity of fluoroquinolone and macrolide antibiotics with phenolic compounds. Front Microbiol (2015) 0.79
Polymyxin Susceptibility in Pseudomonas aeruginosa Linked to the MexXY-OprM Multidrug Efflux System. Antimicrob Agents Chemother (2015) 0.77
New amphiphilic neamine derivatives active against resistant Pseudomonas aeruginosa and their interactions with lipopolysaccharides. Antimicrob Agents Chemother (2014) 0.76
Evaluation of amoebicidal potential of Paneth cell cryptdin-2 against Entamoeba histolytica. PLoS Negl Trop Dis (2011) 0.76
Increased Uptake of Chelated Copper Ions by Lolium perenne Attributed to Amplified Membrane and Endodermal Damage. Int J Mol Sci (2015) 0.75
Branched Peptide, B2088, Disrupts the Supramolecular Organization of Lipopolysaccharides and Sensitizes the Gram-negative Bacteria. Sci Rep (2016) 0.75
Effects of ascorbic acid on Chlamydia trachomatis infection and on erythromycin treatment in primary cultures of human amniotic cells. J Clin Microbiol (1992) 0.75
Polymyxin B induces lysis of marine pseudoalteromonads. Antimicrob Agents Chemother (2007) 0.75
Chlorinated emodin as a natural antibacterial agent against drug-resistant bacteria through dual influence on bacterial cell membranes and DNA. Sci Rep (2017) 0.75
Lysis of gram-negative organisms and the role of versene. Biochim Biophys Acta (1958) 8.52
The outer membrane of Gram-negative bacteria. Adv Microb Physiol (1979) 7.72
Function of the outer membrane of Escherichia coli as a permeability barrier to beta-lactam antibiotics. Antimicrob Agents Chemother (1977) 7.70
Outer membrane of Salmonella typhimurium. Transmembrane diffusion of some hydrophobic substances. Biochim Biophys Acta (1976) 7.44
Physical, chemical, and immunological properties of lipopolysaccharide released from Escherichia coli by ethylenediaminetetraacetate. J Biol Chem (1968) 7.13
Studies on the permeability change produced in coliform bacteria by ethylenediaminetetraacetate. J Biol Chem (1968) 6.06
Outer membrane permeability in Pseudomonas aeruginosa: comparison of a wild-type with an antibiotic-supersusceptible mutant. Antimicrob Agents Chemother (1982) 4.98
Outer membrane protein H1 of Pseudomonas aeruginosa: involvement in adaptive and mutational resistance to ethylenediaminetetraacetate, polymyxin B, and gentamicin. J Bacteriol (1980) 4.93
Involvement of the outer membrane in gentamicin and streptomycin uptake and killing in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1981) 3.95
Permeability of Pseudomonas aeruginosa outer membrane to hydrophilic solutes. J Bacteriol (1982) 3.94
Site of action of polymyxin on Pseudomonas aeruginosa: antagonism by cations. J Gen Microbiol (1954) 3.82
Activity of aminoglycoside antibiotics aganst Pseudomonas aeruginosa: specificity and site of calcium and magnesium antagonism. J Infect Dis (1973) 3.67
Properties of the large ion-permeable pores formed from protein F of Pseudomonas aeruginosa in lipid bilayer membranes. Biochim Biophys Acta (1981) 3.65
Polycations sensitize enteric bacteria to antibiotics. Antimicrob Agents Chemother (1983) 3.33
Polycations as outer membrane-disorganizing agents. Antimicrob Agents Chemother (1983) 3.06
Pseudomonas aeruginosa outer membrane permeability: isolation of a porin protein F-deficient mutant. J Bacteriol (1983) 2.98
Aminoglycoside uptake and mode of action-with special reference to streptomycin and gentamicin. II. Effects of aminoglycosides on cells. J Antimicrob Chemother (1981) 2.29
Effect of polymyxin on the lysis of Neisseria catarrhalis by lysozyme. J Bacteriol (1957) 1.86
Outer membrane permeability barrier disruption by polymyxin in polymyxin-susceptible and -resistant Salmonella typhimurium. Antimicrob Agents Chemother (1981) 1.79
Disruption of the Escherichia coli outer membrane permeability barrier by immobilized polymyxin B. J Antibiot (Tokyo) (1977) 1.62
Alteration of susceptibility to EDTA, polymyxin B and gentamicin in Pseudomonas aeruginosa by divalent cation regulation of outer membrane protein H1. J Gen Microbiol (1983) 1.56
Effects of organic cations on the gram-negative cell wall and their bactericidal activity with ethylenediaminetetra-acetate and surface active agents. J Gen Microbiol (1967) 1.47
Resistance of Pseudomonas aeruginosa to antimicrobial drugs. Prog Med Chem (1975) 1.42
Tris(hydroxymethyl)aminomethane buffer modification of Escherichia coli outer membrane permeability. J Bacteriol (1981) 1.42
Chelation in experimental Pseudomonas keratitis. Br J Ophthalmol (1970) 1.23
Changes in Escherichia coli cell envelope structure and the sites of fluorescence probe binding caused by carbonyl cyanide p-trifluoromethoxyphenylhydrazone. Biochemistry (1977) 1.23
The role of tris in EDTA toxicity and lysozyme lysis. J Gen Microbiol (1967) 1.23
Bactericidal action of ascorbic acid on Psuedomonas aeruginosa: alteration of cell surface as a possible mechanism. Chemotherapy (1978) 0.98
Inhibition of Pseudomonas aeruginosa by ascorbic acid acting singly and in combination with antimicrobials: in-vitro and in-vivo studies. Med J Aust (1974) 0.83
Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature (2000) 32.30
Outer membrane of Pseudomonas aeruginosa: heat- 2-mercaptoethanol-modifiable proteins. J Bacteriol (1979) 9.28
Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonas aeruginosa and Salmonella typhimurium strains. J Bacteriol (1983) 8.19
Outer membranes of gram-negative bacteria. XIX. Isolation from Pseudomonas aeruginosa PAO1 and use in reconstitution and definition of the permeability barrier. J Bacteriol (1978) 7.66
Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains. Infect Immun (1983) 6.24
Outer membrane permeability in Pseudomonas aeruginosa: comparison of a wild-type with an antibiotic-supersusceptible mutant. Antimicrob Agents Chemother (1982) 4.98
Outer membrane protein H1 of Pseudomonas aeruginosa: involvement in adaptive and mutational resistance to ethylenediaminetetraacetate, polymyxin B, and gentamicin. J Bacteriol (1980) 4.93
Con--mutants: class of mutants in Escherichia coli K-12 lacking a major cell wall protein and defective in conjugation and adsorption of a bacteriophage. J Bacteriol (1974) 4.63
Iron transport of Escherichia coli K-12: involvement of the colicin B receptor and of a citrate-inducible protein. J Bacteriol (1976) 4.35
Alterations in outer membrane permeability. Annu Rev Microbiol (1984) 4.22
Involvement of the outer membrane in gentamicin and streptomycin uptake and killing in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1981) 3.95
Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli. Biochemistry (1999) 3.88
Identification of the protein producing transmembrane diffusion pores in the outer membrane of Pseudomonas aeruginosa PA01. Biochim Biophys Acta (1979) 3.70
Properties of the large ion-permeable pores formed from protein F of Pseudomonas aeruginosa in lipid bilayer membranes. Biochim Biophys Acta (1981) 3.65
Functional organization of the outer membrane of escherichia coli: phage and colicin receptors as components of iron uptake systems. J Supramol Struct (1976) 3.53
Use of the fluorescent probe 1-N-phenylnaphthylamine to study the interactions of aminoglycoside antibiotics with the outer membrane of Pseudomonas aeruginosa. Antimicrob Agents Chemother (1984) 3.19
Comparative genomics of Helicobacter pylori: analysis of the outer membrane protein families. Infect Immun (2000) 3.13
Interaction of the cyclic antimicrobial cationic peptide bactenecin with the outer and cytoplasmic membrane. J Biol Chem (1999) 3.07
Antibacterial action of structurally diverse cationic peptides on gram-positive bacteria. Antimicrob Agents Chemother (2000) 3.06
Pseudomonas aeruginosa outer membrane permeability: isolation of a porin protein F-deficient mutant. J Bacteriol (1983) 2.98
Bacteriophage resistance in Escherichia coli K-12: general pattern of resistance. J Bacteriol (1975) 2.94
Ion selectivity of gram-negative bacterial porins. J Bacteriol (1985) 2.87
Aminoglycoside uptake and mode of action--with special reference to streptomycin and gentamicin. I. Antagonists and mutants. J Antimicrob Chemother (1981) 2.78
Interaction of polycationic antibiotics with Pseudomonas aeruginosa lipopolysaccharide and lipid A studied by using dansyl-polymyxin. Antimicrob Agents Chemother (1986) 2.74
Outer membrane protein P of Pseudomonas aeruginosa: regulation by phosphate deficiency and formation of small anion-specific channels in lipid bilayer membranes. J Bacteriol (1982) 2.73
Chemical and chromatographic analysis of lipopolysaccharide from an antibiotic-supersusceptible mutant of Pseudomonas aeruginosa. Antimicrob Agents Chemother (1982) 2.64
Iron transport in Escherichia coli K-12. 2,3-Dihydroxybenzoate-promoted iron uptake. Arch Microbiol (1977) 2.62
Monoclonal antibodies against Pseudomonas aeruginosa outer membrane antigens: isolation and characterization. Infect Immun (1982) 2.61
Mode of action of the antimicrobial peptide indolicidin. J Biol Chem (1996) 2.57
Surface localization of Pseudomonas aeruginosa outer membrane porin protein F by using monoclonal antibodies. Infect Immun (1983) 2.51
Heterogeneity of lipopolysaccharides from Pseudomonas aeruginosa: analysis of lipopolysaccharide chain length. J Bacteriol (1988) 2.35
Outer membrane proteins of Pseudomonas aeruginosa serotype strains. J Infect Dis (1982) 2.32
Aminoglycoside uptake and mode of action-with special reference to streptomycin and gentamicin. II. Effects of aminoglycosides on cells. J Antimicrob Chemother (1981) 2.29
Role of Pseudomonas aeruginosa PhoP-phoQ in resistance to antimicrobial cationic peptides and aminoglycosides. Microbiology (2000) 2.21
PhoP-PhoQ homologues in Pseudomonas aeruginosa regulate expression of the outer-membrane protein OprH and polymyxin B resistance. Mol Microbiol (1999) 2.19
Interaction of cationic antimicrobial peptides with model membranes. J Biol Chem (2001) 2.16
Expression in Escherichia coli and function of Pseudomonas aeruginosa outer membrane porin protein F. J Bacteriol (1986) 2.15
Antiendotoxin activity of cationic peptide antimicrobial agents. Infect Immun (1996) 2.13
Pseudomonas aeruginosa outer membrane: peptidoglycan-associated proteins. J Bacteriol (1981) 2.06
Role of porins in outer membrane permeability. J Bacteriol (1987) 2.06
The rare outer membrane protein, OmpL1, of pathogenic Leptospira species is a heat-modifiable porin. Infect Immun (1995) 2.03
Interactions of bacterial cationic peptide antibiotics with outer and cytoplasmic membranes of Pseudomonas aeruginosa. Antimicrob Agents Chemother (2000) 1.99
Salmonella typhimurium infection and lipopolysaccharide stimulation induce similar changes in macrophage gene expression. J Immunol (2000) 1.93
Cationic antimicrobial peptides and their multifunctional role in the immune system. Crit Rev Immunol (2000) 1.93
Interaction of macrophage cationic proteins with the outer membrane of Pseudomonas aeruginosa. Infect Immun (1988) 1.92
Binding of polycationic antibiotics and polyamines to lipopolysaccharides of Pseudomonas aeruginosa. J Bacteriol (1985) 1.90
PhyloBLAST: facilitating phylogenetic analysis of BLAST results. Bioinformatics (2001) 1.89
Involvement of outer membrane of Pseudomonas cepacia in aminoglycoside and polymyxin resistance. Antimicrob Agents Chemother (1986) 1.87
Lipopolysaccharide-deficient, bacteriophage-resistant mutants of Escherichia coli K-12. J Bacteriol (1976) 1.86
Evidence for two distinct mechanisms of resistance to polymyxin B in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1984) 1.81
Pseudomonas aeruginosa outer membrane protein F: structural role and relationship to the Escherichia coli OmpA protein. J Bacteriol (1989) 1.81
Salt-resistant alpha-helical cationic antimicrobial peptides. Antimicrob Agents Chemother (1999) 1.78
Monoclonal antibodies specific for Escherichia coli J5 lipopolysaccharide: cross-reaction with other gram-negative bacterial species. Infect Immun (1984) 1.77
Negative regulation of the Pseudomonas aeruginosa outer membrane porin OprD selective for imipenem and basic amino acids. Antimicrob Agents Chemother (1999) 1.76
The colicin I receptor of Escherichia coli K-12 has a role in enterochelin-mediated iron transport. FEBS Lett (1976) 1.68
Isolation of the outer membranes from Treponema pallidum and Treponema vincentii. J Bacteriol (1994) 1.67
Isolation of the outer membrane and characterization of the major outer membrane protein from Spirochaeta aurantia. J Bacteriol (1987) 1.67
Pore-forming properties of the major 53-kilodalton surface antigen from the outer sheath of Treponema denticola. Infect Immun (1993) 1.66
Quantitation and identification of antibodies to outer-membrane proteins of Pseudomonas aeruginosa in sera of patients with cystic fibrosis. J Infect Dis (1984) 1.62
Dissociation of antimicrobial and hemolytic activities in cyclic peptide diastereomers by systematic alterations in amphipathicity. J Biol Chem (1999) 1.61
Characterization of two surface-localized antigenic sites on porin protein F of Pseudomonas aeruginosa. Can J Microbiol (1985) 1.58
Helicobacter pylori uptake and efflux: basis for intrinsic susceptibility to antibiotics in vitro. Antimicrob Agents Chemother (2000) 1.58
Structure of the bovine antimicrobial peptide indolicidin bound to dodecylphosphocholine and sodium dodecyl sulfate micelles. Biochemistry (2000) 1.57
Alteration of susceptibility to EDTA, polymyxin B and gentamicin in Pseudomonas aeruginosa by divalent cation regulation of outer membrane protein H1. J Gen Microbiol (1983) 1.56
Synergistic interactions between mammalian antimicrobial defense peptides. Antimicrob Agents Chemother (2001) 1.56
Isolation and characterization of a family of porin proteins from Helicobacter pylori. Infect Immun (1995) 1.52
Cutting edge: cationic antimicrobial peptides block the binding of lipopolysaccharide (LPS) to LPS binding protein. J Immunol (2000) 1.51
Improvement of outer membrane-permeabilizing and lipopolysaccharide-binding activities of an antimicrobial cationic peptide by C-terminal modification. Antimicrob Agents Chemother (1994) 1.51
Modulation of structure and antibacterial and hemolytic activity by ring size in cyclic gramicidin S analogs. J Biol Chem (1996) 1.50
Mitogenic effects of purified outer membrane proteins from Pseudomonas aeruginosa. Infect Immun (1980) 1.48
Influence of proline residues on the antibacterial and synergistic activities of alpha-helical peptides. Biochemistry (1999) 1.48
Sequencing solution: use volunteer annotators organized via Internet. Nature (2000) 1.46
Demonstration and chemical modification of a specific phosphate binding site in the phosphate-starvation-inducible outer membrane porin protein P of Pseudomonas aeruginosa. Biochim Biophys Acta (1986) 1.42
Improved activity of a synthetic indolicidin analog. Antimicrob Agents Chemother (1997) 1.41
Porin activity and sequence analysis of a 31-kilodalton Treponema pallidum subsp. pallidum rare outer membrane protein (Tromp1). J Bacteriol (1995) 1.41
Role of Pseudomonas aeruginosa outer membrane protein OprH in polymyxin and gentamicin resistance: isolation of an OprH-deficient mutant by gene replacement techniques. Antimicrob Agents Chemother (1992) 1.41
Biological properties of structurally related alpha-helical cationic antimicrobial peptides. Infect Immun (1999) 1.40
Outer membrane porin proteins F, P, and D1 of Pseudomonas aeruginosa and PhoE of Escherichia coli: chemical cross-linking to reveal native oligomers. J Bacteriol (1983) 1.40
The interaction of a recombinant cecropin/melittin hybrid peptide with the outer membrane of Pseudomonas aeruginosa. Mol Microbiol (1994) 1.40
Interaction of cationic peptides with lipoteichoic acid and gram-positive bacteria. Infect Immun (1999) 1.40
Outer-membrane protein PhoE from Escherichia coli forms anion-selective pores in lipid-bilayer membranes. Eur J Biochem (1984) 1.38
Transgenic plants expressing cationic peptide chimeras exhibit broad-spectrum resistance to phytopathogens. Nat Biotechnol (2000) 1.37
A pleiotropic, posttherapy, enoxacin-resistant mutant of Pseudomonas aeruginosa. Antimicrob Agents Chemother (1992) 1.37
Construction and characterization of Pseudomonas aeruginosa protein F-deficient mutants after in vitro and in vivo insertion mutagenesis of the cloned gene. J Bacteriol (1988) 1.35
Pseudomonas aeruginosa pili as ligands for nonopsonic phagocytosis by fibronectin-stimulated macrophages. Infect Immun (1989) 1.35
Genetic definition of the substrate selectivity of outer membrane porin protein OprD of Pseudomonas aeruginosa. J Bacteriol (1993) 1.34
Mechanism of ion transport through the anion-selective channel of the Pseudomonas aeruginosa outer membrane. J Gen Physiol (1987) 1.33
Immunogenicity of Pseudomonas aeruginosa outer membrane antigens examined by crossed immunoelectrophoresis. Infect Immun (1983) 1.33
Membrane topology and site-specific mutagenesis of Pseudomonas aeruginosa porin OprD. Mol Microbiol (1995) 1.33
Improved derivatives of bactenecin, a cyclic dodecameric antimicrobial cationic peptide. Antimicrob Agents Chemother (1999) 1.32
Phosphate transport in Pseudomonas aeruginosa. Involvement of a periplasmic phosphate-binding protein. Eur J Biochem (1984) 1.32
Isolation and characterization of a conserved porin protein from Helicobacter pylori. J Bacteriol (1995) 1.31
Gramicidin S is active against both gram-positive and gram-negative bacteria. Int J Pept Protein Res (1996) 1.31
Role of porins in intrinsic antibiotic resistance of Pseudomonas cepacia. Antimicrob Agents Chemother (1987) 1.29
Antimycobacterial polyynes of Devil's Club (Oplopanax horridus), a North American native medicinal plant. J Nat Prod (1997) 1.29
Cross-resistance between bacteriophages and colicins in Escherichia coli K-12. J Bacteriol (1976) 1.28
Outer membrane protein H1 of Pseudomonas aeruginosa: purification of the protein and cloning and nucleotide sequence of the gene. J Bacteriol (1989) 1.27
Influence of outer membrane mutations on susceptibility of Escherichia coli to the dibasic macrolide azithromycin. J Antimicrob Chemother (1992) 1.27
Structure and mechanism of action of an indolicidin peptide derivative with improved activity against gram-positive bacteria. J Biol Chem (2001) 1.26
Analysis of two gene regions involved in the expression of the imipenem-specific, outer membrane porin protein OprD of Pseudomonas aeruginosa. FEMS Microbiol Lett (1992) 1.25